Status:
COMPLETED
Vitamin D and COVID-19 Management
Lead Sponsor:
University of Alberta
Conditions:
COVID-19
Eligibility:
All Genders
17+ years
Phase:
PHASE3
Brief Summary
A novel coronavirus disease 2019 (COVID-19) outbreak is a global dramatic pandemic that is immeasurably impacting the communities. Due to lack of data, symptomatic management is used for COVID-19 infe...
Detailed Description
In-patients 1. Determine the frequency of low serum Vit D levels (\<50 nmol/L) in COVID-19 patients. 2. Determine the relationship between baseline vitamin D status and disease severity, laboratory b...
Eligibility Criteria
Inclusion
- Patients with COVID-19:
- ≥ 17 years old
- Both sexes
Exclusion
- Patients with dementia, learning disability, mental health needs and alcohol or drug dependency, pregnant women will be excluded.
- Patients with sarcoidosis, hypercalcemia, known vitamin D intolerance
Key Trial Info
Start Date :
March 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2024
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04385940
Start Date
March 19 2021
End Date
July 2 2024
Last Update
January 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2R3